Breakthrough Lung Cancer Detection Test Trial On High Risk Smokers

A breakthrough lung cancer detection test is set to be trialled on smokers for the first time in Scotland.

If successful, cancers could be identified five years earlier than by current detection methods.

The simple blood test (EarlyCDT-Lung) developed by Oncimmune Ltd, locates immune biomarkers (antibodies) that are produced in the blood when lung cancer is present, which could help signal early signs of a tumour to doctors.

Although antibody testing has been around for a number of years, this is the first time it has been sensitive enough to detect cancer.

Sir Harry Burns, Scotland's Chief Medical Officer, has announced that pilot trials of the blood test will go ahead in Scotland and initially be tested on 10,000 heavy smokers (those who smoke at least 20 cigarettes a day).

The 'Detect Cancer Early' screening programme will begin before the end of this year and the first set of results are expected in 2014.

In a statement released today, Sir Harry Burns said: “The earlier a cancer is diagnosed the greater the chance it can be treated successfully, and currently 85% of patients with lung cancer remain undiagnosed until the disease has reached an advanced stage.

“By testing those at greatest risk of developing lung cancer, and diagnosing it at its earliest possible stage, we stand a better chance of being able to treat the cancer successfully."

In the UK, lung cancer is the second most common cancer, the biggest killer in women, with over 41,000 people diagnosed with the disease each year.

Scotland has one of the highest rates of lung cancer in the world and the lowest survival rate five years after diagnosis. Lung cancer survival rates in the UK have remained poor for decades.

Professor John Robertson of Oncimmune Ltd believes the test will lead to significant improvement in prognosis for substantial numbers of lung cancer sufferers: “A blood test to aid detection of all tumour cancers (70% of all cancer) is still the overriding objective of our work,” he said in the same statement.

Dr Keith Prowse from the British Lung Foundation told the BBC: "Survival rates for lung cancer in the UK are alarmingly low with approximately 29% of patients still alive after only one year.

"Detecting lung cancer early means a patient can be operated on and will increase their chance of survival. This is a very exciting trial which we hope can be rolled out across the UK."

A twice-daily skin cancer drug almost doubles the survival times of advanced cancer patients, American scientists have discovered.
Researchers from the Jonsson Cancer Center at the University of California, found that advanced melanoma cancer sufferers lived on average of 16 months after receiving the vemurafenib drug.
Read the full story here.
Read the full story here

Scientists have discovered five new genes that cause heart attacks and strokes and hope these findings will enable them to pinpoint when the attacks will strike.
The researchers, from Queen Mary University of London, identified five generic variants that trigger heart attacks and strokes after investigating blood pressure measurements of 25,000 participants. The aim of the study was to look into the role that genes play in hypertension and high blood pressure.
Read the full story here.

American scientists have discovered a potential new drug that could help fight against Alzheimer's disease.
Neuroscientists from the Case Western Reserve University School of Medicine discovered that a skin cancer drug called bexarotene appears to reverse cognitive and memory deficits associated with Alzheimer's when tested on lab mice.
Read the full story here.

A "personalised" pill for advanced skin cancer that can extend life has been approved for use in the UK.
The drug, vemurafenib, only works for patients with a specific variant of the BRAF gene.
Read the full story here.

The genetic code of the most common form of hereditary breast cancer has been mapped for the first time, offering hope for diagnosis and treatment of the disease in the future.
Researchers say they have "fully sequenced" the DNA of two breast cancers caused by a faulty BRCA1 gene, which is responsible for aggressive and highly drug-resistant tumours.
Read the full story here.

Scientists from the Northwestern University in Chicago have come one step closer to developing a potential cure for peanut allergies, by creating an immune system tolerant to peanuts. The researchers found that they can switch off potentially deadly peanut allergy attacks by tricking the immune system into tolerating nut proteins, and not seeing them as a threat to the body.
Read the full story here.

A breakthrough lung cancer detection test is set to be trialled on smokers for the first time in Scotland.
If successful, cancers could be identified five years earlier than by current detection methods.
Read the full story here.

Sleepless nights could soon be a thing of the past as scientists discover a key chemical trigger that suppresses sleep and wakes people up. Researchers from Boston University found that when the body has too little of the calcium kinase enzyme, it causes the brain to nod off to sleep.
Read the full story here.

A new treatment for breast cancer has been discovered after scientists found that breast tumours can be killed in minutes - by boiling them. The latest treatment, known as Preferential Radio-Frequency Ablation, uses a targeted electrical current that heats, or 'boils' the tumour to 70 to 90c (160 to 190f).
Read the full story here.

British scientists have developed a revolutionary breast-screening system that uses anti-landmine technology to detect cancer in seconds. The radio-wave scanner is safer, cheaper and less painful than traditional mammogram X-rays, and unlike the current system, can be used on women of all ages.
Read the full story here.

Breakthrough research involving a brain transplant of stem cells could offer hope for the treatment of both autism and Parkinson's disease.
The study, from Harvard University, has already proven successful with mice. Scientists transferred healthy stem cells from mouse embryos into the brains of adult mice who were unable to use leptin, a hormone that tells the body when to stop eating.
Read the full story here.

A stomach implant that can trick the brain into thinking the stomach is full is the latest hi-tech gadget that experts hope will help fight the flab and beat obesity. The Abiliti, or 'Gastric Pacemaker', is a credit card-sized implant, inserted using keyhole surgery, which detects when food has been eaten and sends signals to the brain to create the feeling of fullness.
Read the full story here.

Scientists from the Imperial College London have discovered a 'fertility switch' that could help treat infertility and miscarriage in the future. The study, published in the Nature Medicine journal, discovered an enzyme in the body that determines infertility and the chances of miscarriage, as it acts like a 'switch'.
Read the full story here.

Eviplera, a new once-daily pill for the treatment of HIV has been made available in 27 countries of the European Union following approval by the European Medicines Agency. The new drug, from Gilead Sciences, combines three antiretroviral treatments in a single tablet so HIV patients only need to take one tablet a day to treat their condition.
Read the full story here.

Scientists believe that a potent Alzheimer's vaccine jab could be the secret to preventing the disease developing from its early stages. Researchers from Georgetown University Medical Center in Washington found that an antibody for Alzheimer's disease is more likely to trigger inflammation in the brain the later it is given and that it could potentially be prevented, as long as the vaccine is taken during the very early stages of the disease.
Read the full story here.